• Story Reviews
  • News Release Reviews
  • Blog
  • Podcasts
  • About Us
  • Toolkit for journalists and consumers
  • Contact
  • Newsletter Signup
HealthNewsReview.org HealthNewsReview.org HealthNewsReview.org
  • 2616 Story Reviews
  • 606 News Release Reviews
  • 2944 Blog Posts
  • Home
  • Story Reviews
  • News Release Reviews
  • Blog
  • Podcasts
  • About Us
    • Editorial Team
    • What We Review and How
    • Review Criteria
    • How Is the Star Score Determined?
    • Our Comments Policy
    • Accolades for HealthNewsReview.org
    • Talks, Workshops & Presentations
  • Toolkit
    • Tips for Analyzing Studies & Health Care Claims
    • Just for Journalists: Writing Tips
    • Stories of Patient Harm from Misleading Media
    • Pre-publication News Release Review
    • Health News Watchdog podcasts
    • News Sites & Blogs We Like
    • List of Industry-Independent Experts
    • Links to Other Resources
  • Contact

Search Results for "alzheimer's treatment"

1
7/27/2018

Many questions linger about this possible Alzheimer’s treatment. So why the avalanche of news coverage?

News organizations rightly reported the numerous asterisks attached to a small mid-stage study of a potential Alzheimer’s treatment highlighted at this week’s Alzheimer’s Association International Conference. As some stories reported, the study was a Phase 2 trial that hasn’t been peer reviewed or published in a journal, in which the drug didn’t meet its primary […]

June 24, 2016 | Story Review

CBS News story on Alzheimer’s treatment follows familiar formula

The story follows a tired formula of teasing readers with hopeful statements about a potential cure, only to conclude with the caveat that more study is needed to determine whether the idea will actually work.

2 Star
CBSNews.com

Can memory loss in Alzheimer's patients be reversed?

April 16, 2015 | News Release Review

Spinning of negative result gives false hope on Alzheimer’s treatment

Subgroup analysis is an important approach to experimental trials that journalists – and the general  public need to understand.  This news release didn’t even raise the issue.

2 Star

Prostate Cancer Drug Slows Memory Loss in Women with Alzheimer's Disease

October 29, 2012 | Story Review

Israeli medical device offers new Alzheimer’s treatment

6 people in the active arm of the study.  Unpublished data.  Everything comes from the company.  Even investors reading a business story deserve better than this.

1 Star
Reuters Health

Israeli medical device offers new Alzheimer’s treatment

January 30, 2015 | Story Review

Nasal spray shows promise as treatment for Alzheimer’s disease

Longer but not better than a competing Washington Post column about the same study. An independent voice could have helped frame these results with the appropriate context.

2 Star
FoxNews.com

Nasal spray shows promise as treatment for Alzheimer’s disease

4/12/2011

New questions about treatments for spinal fusion, Alzheimer’s

The New York Times reports, “Medtronic Bone-Growth Product Scrutinized.” Excerpt: “One of Medtronic’s most profitable divisions — selling bone growth products used in spinal fusion procedures — faces growing pressure amid a widening criminal investigation into the company’s marketing of one product and a rejection by federal regulators of another one. Recently, the Food and […]

7/28/2020

What you need to know about the Alzheimer’s test news

For years, substances called tau protein or beta-amyloid have been theorized to be signs or causes of Alzheimer’s disease.  There have been many reports of tests and treatments based on theories that tau and/or amyloid are at least signs, if not causes, of Alzheimer’s. Scientific uncertainty remains about the precise role of tau and amyloid […]

December 19, 2018 | Story Review

Guardian jumps to conclusions about an Alzheimer’s study that hasn’t even begun

The story’s headline states: “Virtual reality to help detect early risk of Alzheimer’s.” That is misleading. The researchers haven’t even recruited study participants yet, much less conducted the study or analyzed the results.

1 Star
The Guardian

Virtual reality to help detect early risk of Alzheimer’s

December 13, 2018 | News Release Review

Johns Hopkins prematurely heralds a ‘promising diagnostic tool’ for Alzheimer’s

This news release did a good job of explaining how the study was done but didn’t provide data on benefits, costs, or harms.

3 Star
Johns Hopkins Medicine

Johns Hopkins team identifies promising diagnostic tool for Alzheimer's disease

November 28, 2018 | Story Review

USA Today provides rosy speculation about an Alzheimer’s vaccine not yet tested in humans

The story played up wishful conjecture about slashing dementia cases in half.

3 Star
USA Today

Researcher: Alzheimer's vaccine could cut dementia in half, human trials may be next

9/4/2018

Podcast: The problematic promise of a ‘cure’ for Alzheimer’s disease

The Alzheimer’s Association has fundraising commercials promising breakthroughs and cures for a disease in which the cause is unknown and a treatment hasn’t been found.

Is this irresponsible? Unethical? Potentially harmful?

9/4/2018

Podcast: The problematic promise of a ‘cure’ for Alzheimer’s disease

The Alzheimer’s Association has fundraising commercials promising breakthroughs and cures for a disease in which the cause is unknown and a treatment hasn’t been found. Is this irresponsible? Unethical? Potentially harmful?

3
Conflicts of interest in healthcare
8/27/2018

How the ‘optimism’ narrative in Alzheimer’s helps the drug industry and harms patients

When I think about what will be lost when HealthNewsReview.org closes its doors at the end of 2018, our emphasis on independent expert assessment of health care claims looms as one of the biggest deficits. We’ve pointed out time and again how health care news can be tainted by the influence of industry and hidden […]

July 25, 2018 | Story Review

HealthDay provides needed details on side effects of THC-based drug studied for Alzheimer’s agitation

However, the story didn’t provide any supporting numbers for the touted benefits.

4 Star
Health Day

Could Pot-Linked Drug Help Ease Agitation in Alzheimer's?

June 14, 2018 | News Release Review

No, an asthma drug tested in mice does not bring ‘new hope’ for Alzheimer’s patients, at least not yet

Use of use of words like “breakthrough” and a phrase suggesting the drug offers “new hope” for patients detract from the cautious aspects of this release.

1 Star
Temple University Health System

Temple researchers reverse cognitive impairments in mice with dementia

  • 1
  • 2
  • 3
  • …
  • 9
  • Next »

Toolkit

Tips & Resources for Analyzing Health Care Claims

Surrogate markers may not tell the whole story

Screening: How overdiagnosis and other harms can undermine the benefits

A place to tell stories of patient harm from misleading media

View More

Toolkit

Institutional Home

University of Minnesota - School of Public Health
  • Home
  • Story Reviews
  • News Release Reviews
  • Blog
  • About Us
  • Toolkit
  • Contact

Copyright © 2022 HealthNewsReview.org